Skip to main content

Advertisement

Table 1 Distribution of cytokines scores at the start of treatment by autoantibodies

From: Biologic predictors of clinical improvement in rituximab-treated refractory myositis

Baseline Anti-synthetase TIF SRP MJ MI-2 Other AutoAb No AutoAb Undefined P value
(N = 28) (N = 19) (N = 21) (N = 18) (N = 25) (N = 24) (N = 33) (N = 9)  
IFNCKa 43.3 30.9 11.8 18.7 29.9 21.2 13.4 23.2 <.001
(1.4, 100.0) (7.9, 85.9) (1.9, 49.3) (4.1, 66.2) (5.0, 87.2) (2.9, 85.7) (2.5, 72.1) (5.7, 65.4)
TH1 27.9 23.3 19.6 21.9 21.8 26.4 20.7 22.2 0.070
(6.1, 80.5) (13.5, 77.1) (9.5, 88.9) (3.8, 80.6) (17.2, 51.6) (16.6, 49.0) (10.2, 76.2) (12.5, 93.3)  
TH2 11.7 10.8 10.1 10.3 9.5 11.7 10.6 10.9 0.12
(5.4, 47.8) (6.8, 52.5) (2.4, 93.7) (2.2, 89.8) (6.5, 21.4) (7.6, 88.4) (6.7, 82.8) (3.5, 34.8)
TH17 28.1 22.8 22.6 27.6 20.7 24.5 22.4 33.1 0.24
(13.0, 79.2) (12.7, 48.9) (13.5, 62.5) (8.6, 74.6) (11.2, 47.8) (15.4, 53.9) (8.9, 40.1) (14.8, 68.5)
Innate 49.3 31.0 28.4 33.3 31.0 33.6 27.0 37.8 0.001
(19.1, 74.8) (15.5, 54.9) (11.7, 54.4) (18.1, 71.2) (17.0, 53.1) (17.4, 61.6) (16.2, 58.5) (18.2, 63.8)
Regulatory 31.1 23.0 21.0 23.1 19.9 32.2 21.1 19.9 0.010
(13.0, 75.6) (10.6, 100.0) (7.5, 100.0) (3.5, 82.1) (15.7, 55.1) (14.6, 75.1) (11.6, 76.8) (15.4, 69.5)
  1. aIFNCK IFN chemokine score